Abstract: The present invention provides a method for preparing a pharmaceutical formulation containing ivermectin and a method and composition that can contain ivermectin plus hexahydropyrazinoisoquinolines, tetrahydropyrimidines and benzimidazoles or febantel. Examples of hexahydropyrazinoisoquinolines, tetrahydropyrimidines and benzimidazoles include praziquantel, pyrantel pamoate and fenbendazole, respectively. A pharmaceutical formulation is provided for use in the treatment of helminthiasis of mammals, and particularly tapeworm, hookworm, roundworm, whipworm and heartworm of domestic animals and farm animals. The present invention also provides a method of treating helminthiasis in mammals, which method comprises administering to the mammal in need thereof an anthelmintically effective amount of a pharmaceutical formulation of the invention.
Type:
Grant
Filed:
March 12, 2004
Date of Patent:
July 8, 2008
Assignees:
Virbac Corporation, The Hartz Mountain Corporation
Inventors:
Ian Cottrell, Arima Das Nandy, Albert Ahn, Richard Fisher
Abstract: A reusable device for continuously monitoring gaseous ammonia concentration in a surrounding environment comprising a plurality of layers, including an active layer in which a dye (e.g., an indicator dye useful for measurement of pH) is immobilized to a membrane (e.g., polyamide membrane), and a hydrophobic filter layer capable of permitting contact between the active membrane and dissolved gaseous ammonia.
Type:
Application
Filed:
January 25, 2007
Publication date:
February 21, 2008
Applicant:
Virbac Corporation
Inventors:
Roni Kopelman, Stuart Jamieson, John Thuma
Abstract: The present invention relates to devices, methods, and kits for quickly and easily measuring and monitoring the pH of aquatic environments, such as lakes, streams, drinking waters, fisheries, aquariums, pools, hot-tubs, and spas. The current invention includes devices that are reusable and capable of monitoring the pH in a reversible fashion, thereby allowing continuous pH sensing without a need for the user to physically perform pH tests. Operation of the invention involves placing the device into the aquatic environment and optically detecting a color change in the membrane, for example, by looking at the device, when a pH measurement is desired. In addition, the device is both inexpensive and reusable, allowing the user to monitor the pH of various aquatic environment at minimal costs.
Abstract: The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive.
Type:
Grant
Filed:
January 3, 2003
Date of Patent:
May 10, 2005
Assignee:
Virbac SA
Inventors:
Ahmed El Hadri, Philippe Archimbault, Gérard Leclerc, Arthur Donny Strosberg, France Pietri-Rouxel
Abstract: Injectable compositions containing a liquid solvent free of solid polymers, anthelmintic agent(s)and hormonal growth promoter(s), where the anthelmintic agent(s) and the hormonal growth promoter(s) are dissolved in the polymer free solvent system. The present invention additionally relates to methods of promoting animal growth and inhibiting parasitic infection/infestation with these compositions, as well as methods of preparing such compositions.
Type:
Grant
Filed:
September 30, 2002
Date of Patent:
November 25, 2003
Assignee:
Virbac S.A.
Inventors:
Vincent Beuvry, Georges Bufala, Guy Derrieu
Abstract: The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive. These derivatives comply with the general formula (I) in which R2 represents one of the following groups: —CH2—, —CH2—CH2, —CH(CH3)—CH2—, —C(CH3)═CH—, —C(CH3)2—CH2— or a bond; Q represents: (i) a phenyl radical 3,4-disubstituted alkylene dioxy determining with the phenyl radical, a non-substituted benzodioxane unit, a non-substituted benzodioxol unit, or a 2-substituted benzodioxol unit, (ii) a phenyl radical 3 and/or 4-substituted, by a O—(CH2)x—COOR5 group, (iii) a condensed polycyclic hydrocarbon comprising at least two condensed cycles, (iv) a cyclic hydrocarbon system, optionally cross-linked, and constituting a cycloalkane comprising 1, 2 or 3 cycles.
Type:
Application
Filed:
January 3, 2003
Publication date:
August 21, 2003
Applicant:
VIRBAC SA
Inventors:
Philippe Archimbault, Gerard Leclerc, Arthur Donny Strosberg, France Pietri-Rouxel
Abstract: The subject of the present invention is the use of a preparation comprising:
a) from 1 to 50% by weight, relative to the total weight of the preparation, of at least one compound chosen from chondroitin sulfates and their salts, and
b) from 1 to 66% by weight, relative to the total weight of the preparation, of at least one compound chosen from chitosan, its salts, its derivatives and the salts of these derivatives, for the preparation of a composition for the prevention or treatment of rheumatic conditions by the general route, and, in particular, for the prevention or treatment of degenerative arthropathies.
Abstract: The present invention relates to compositions which contain at least one cationic polymer and at least one active molecule contained in at least one micro or nanoparticulate vector, and their use for treating living or inert surfaces.
Type:
Grant
Filed:
April 14, 1998
Date of Patent:
December 31, 2002
Assignee:
Virbac
Inventors:
Guy Derrieu, Jean-Luc Pougnas, Patricia Monginoux, Christian Karst
Abstract: A device for dispensing an active substance to be used in a biological medium, in particular in the rumen of an animal, includes a sealed receptacle for containing the substance, and having at least one opening; a closure for provisionally closing the opening of the receptacle, the closure being maintained closed by at least one biodegradable element such that subsequent to the biological degradation of the element, the closure completely releases the opening.
Abstract: Device designed to be carried by an animal and capable of controlled release of one or several active principles and, more particularly, one or several medicinal active principles to protect and/or treat this animal against possible pathologies, and capable of being used as a restraint for controlling and managing the animal. In one embodiment the device is used with a leash or lead fixed to the device. Method for making the device. The device comprises a first material for the controlled release of one or several active substances of polymer matrix type containing this active substance and a second material for providing it with mechanical resistance, the materials being closely bound within a single structure.
Type:
Grant
Filed:
September 5, 2000
Date of Patent:
May 7, 2002
Assignee:
Virbac
Inventors:
Guy Derrieu, Bruno Roy, Christian Karst, Thierry Grenier
Abstract: The invention concerns aryloxypropanolamnine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive. These derivatives comply with the general formula (I) in which R2 represents one of the following groups: —CH2—, —CH2—CH2, —CH(CH3)—CH2—C(CH3)—CH—, —C(CH3)2—CH2— or a bond; Q represents: (i) a phenyl radical 3,4-substituted alkylene dioxy determining with the phenyl radical, a non-substituted benaodioxane unit, a non-substituted benzodioxol unit, or a 2-substituted benzodioxol unit, (ii) a phenyl radical 3 and/or 4-substituted, by a O—(CH2)x—COOR5 group, (iii) a condensed polycyclic hydrocarbon comprising at least two condensed cycles, (iv) a cyclic hydrocarbon system, optionally cross-linked, and constituting a cycloalkane comprising 1, 2 or 3 cycles.
Type:
Application
Filed:
August 23, 2001
Publication date:
February 14, 2002
Applicant:
VIRBAC SA
Inventors:
Archimbault Philippe, Leclerc Gerard, Strosberg Arthur Donny, Pietri-Rouxel France
Abstract: The invention concerns pharmaceutical compositions with antimalaria and antibabesiosis activity, the active substances of these compositions and their use for formulating antimalaria drugs.
Type:
Grant
Filed:
February 1, 1999
Date of Patent:
August 1, 2000
Assignee:
Virbac S.A.
Inventors:
Henri Vial, Michele Calas, Marie-Laure Ancelin, Louis Giral
Abstract: Composition and system for oral administration of chemicals or medicaments, and applications thereof (for example as medicament, dietetic product, food product, bait). Said composition comprises essentially (a) from 3% to 20% by weight of at least one water-insoluble polymer selected from the polyamides and ethylene copolymers such as ethylene/vinyl acetate; (b) from 35% to 60% by weight of lipidic substances, at least one of these lipidic substances being solid at room temperature, the melting point of the solid lipidic substance(s) being lower than that of the polymer(s); (c) from 5% to 45% of at least one paletable substance; (d) from 0% to 50% of another suitable complementary ingredient. Said composition can be obtained by (i) melting of the solid lipidic substances at a temperature lower than the melting point of the polymer(s), and (ii) mixing of the polymer(s) and the other constituents at the same temperature as for (i). A method of preparing said systems and composition is also disclosed.
Type:
Grant
Filed:
May 22, 1996
Date of Patent:
January 4, 2000
Assignee:
Laboratories Virbac
Inventors:
Guy Derrieu, Bernard Raynier, Jean-Luc Pougnas, Luc Castelli
Abstract: Water soluble, powder form compositions suitable for completely and rapidly dissolving active ingredients which usually only dissolve in water in the presence of base salts, such as antibiotics of the betalactamide family, for example penicillins and their derivatives, cephalosporins and their derivatives, or other active ingredients such as sulphamides and quinolones, for oral absorption thereof and their applications. The water soluble powder form compositions contain, in combination and in powder form, at least one water soluble active ingredient, not in salt form, and with an exclusively alkaline pH, an excess of one or more strong base salts, and one or more buffers comprising one or more substances and capable of maintaining the pH of the medium at a level below the normal solubilization pH of said active ingredient. Aqueous solution compositions obtained from said powder form compositions are also described.
Type:
Grant
Filed:
December 22, 1997
Date of Patent:
August 10, 1999
Assignee:
Virbac SA
Inventors:
Guy Derrieu, Jean-Luc Pougnas, Olivier Broussaud
Abstract: The invention relates to an avirulent anti-rabies vaccine which consists of an avirulent mutant of an SAD strain of the rabies virus, the glycoprotein of which possesses in position 333 a naturally occurring amino acid whose codon differs from those of arginine by at least two nucleotides.
Abstract: Substituted bis-2-aminopyridines of formula (1), wherein Q, R1,R2,R3,R4 are as defined in the specification. A method for preparing said compounds and the use thereof as a drug and in particular as active drugs for controlling parasiticc infections within red blood cells, e.g. malaria or babesiasis.
Type:
Grant
Filed:
July 2, 1997
Date of Patent:
November 10, 1998
Assignee:
Virbac
Inventors:
Henri Vial, Michele Calas, Jean-Jacques Bourguignon, Marie-Laure Ancelin, Louis Giral
Abstract: The Invention relates to an anthelmintic composition for oral use comprising an effective amount of praziquantel and an effective amount of at least one anthelmintic agent selected from avermectins, milbemycins or derivatives thereof and to a method for controlling and treating infestations by cestodes and nematodes in equine animals comprising orally administering such a composition to said animals.
Abstract: The present invention provides a process for the in vitro culture of parasites of the genus Babesia, processes for the in vitro attenuation of the virulence of these parasites, processes for the in vitro cloning of these parasites, attenuated parasites, clonal lines of the genus Babesia, nucleotide probes derived from the clonal lines, the use of these probes for the identification of Babesia parasites and to vaccinces against babesioses.
Type:
Grant
Filed:
September 8, 1995
Date of Patent:
October 20, 1998
Assignee:
Laboratoires Virbac
Inventors:
Philippe Mahl, Marie-Helene Dick-Madelpuech
Abstract: Device capable of being used in combination with a restraining or ornamental collar or with any other support for animals, intended to make possible the controlled and optically continuous and complete release of chemical substances, including medicaments, for more or less lengthy, continuous or noncontinuous, periods and process for producing the said device. The device comprises a polymeric matrix enclosing at least one active substance capable of being released towards an appropriate area of an animal. The device is composed of at least one tubular component of any cross-section, containing at least one layer of flexible polymeric matrix containing at least one active substance, the length of the said tubular component can be regulated to adjust the daily dose of the active substance to the weight of the animal and the ratio of the external surface area of said tubular component to the thickness of its' wall is as great as possible to obtain linear removal of the active substance.
Type:
Grant
Filed:
January 19, 1996
Date of Patent:
July 7, 1998
Assignee:
Laboratoires Virbac
Inventors:
Christian Karst, Thierry Gozlan, Guy Derrieu, Luc Castelli